<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">The Clinician</journal-id><journal-title-group><journal-title xml:lang="en">The Clinician</journal-title><trans-title-group xml:lang="ru"><trans-title>Клиницист</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1818-8338</issn><issn publication-format="electronic">2412-8775</issn><publisher><publisher-name xml:lang="en">Publishing House ABV Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">159</article-id><article-id pub-id-type="doi">10.17650/1818-8338-2014-2-17-21</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>ORIGINAL INVESTIGATIONS</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">ADIPOKINES CONTENT AND ECHOCARDIOGRAPHY INDICATORS OF WOMEN WITH HYPOTHYROIDISM</article-title><trans-title-group xml:lang="ru"><trans-title>СОДЕРЖАНИЕ АДИПОКИНОВ И ПОКАЗАТЕЛИ ЭХОКАРДИОГРАФИИ У ЖЕНЩИН С ГИПОТИРЕОЗОМ</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kapralova</surname><given-names>I. Yu.</given-names></name><name xml:lang="ru"><surname>Капралова</surname><given-names>И. Ю.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Verbovoy</surname><given-names>A. F.</given-names></name><name xml:lang="ru"><surname>Вербовой</surname><given-names>А. Ф.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>andreyy.verbovoyy@rambler.ru</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Sharonova</surname><given-names>I. A.</given-names></name><name xml:lang="ru"><surname>Шаронова</surname><given-names>Л. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff2"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Diabetis Center LLC, 56 Sovetskoy Armii St., Samara, 443067, Russia</institution></aff><aff><institution xml:lang="ru">ООО Центр «Диабет», Россия, 443067, Самара, ул. Советской Армии, 56</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Samara State Medical University, Ministry of Health of Russia, 89 Chapayevskaya St., Samara, 443099, Russia</institution></aff><aff><institution xml:lang="ru">ГБОУ ВПО «Самарский государственный медицинский университет» Минздрава России, Россия, 443099, Самара, ул. Чапаевская, 89</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2014-04-15" publication-format="electronic"><day>15</day><month>04</month><year>2014</year></pub-date><volume>8</volume><issue>2</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>17</fpage><lpage>21</lpage><history><date date-type="received" iso-8601-date="2015-01-30"><day>30</day><month>01</month><year>2015</year></date><date date-type="accepted" iso-8601-date="2015-01-30"><day>30</day><month>01</month><year>2015</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2014, Kapralova I.Y., Verbovoy A.F., Sharonova I.A.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2014, Капралова И.Ю., Вербовой А.Ф., Шаронова Л.А.</copyright-statement><copyright-year>2014</copyright-year><copyright-holder xml:lang="en">Kapralova I.Y., Verbovoy A.F., Sharonova I.A.</copyright-holder><copyright-holder xml:lang="ru">Капралова И.Ю., Вербовой А.Ф., Шаронова Л.А.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://klinitsist.abvpress.ru/Klin/article/view/159">https://klinitsist.abvpress.ru/Klin/article/view/159</self-uri><abstract xml:lang="en"><p><bold>Study objective:</bold> to study the adipokines content and echocardiography indicators of women with hypothyroidism.</p><p><bold>Materials and methods</bold>. 30 women with hypothyroidism were included into the study with the average age of 55.2 ± 2.2 years old and the duration of disease of 8.53 ± 0.84 years. Anthropometric parameters of all patients were measured. Levels of leptin, resistin, adiponectin were investigated with enzyme multiplied immunoassay. Morphometric parameters of the left ventricle (LV) were assessed with echocardiography.</p><p><bold>Results.</bold> The examined patients with hypothyroidism displayed increased concentration of leptin and resistin, as well as decreased concentration of adiponectin. Concentric and eccentric hypertrophy of the left ventricle is revealed in more than half of cases with patients with the hypofunction of the thyroid gland.</p><p><bold>Conclusion.</bold> Evident decreasing of the level of adiponektin and increasing of the level of leptin and resistin was revealed with examined patients on the background of the excessive body weight. Hypertrophy of the left ventricle and diastolic dysfunction of the myocard with its relatively preserved contractile ability was revealed with women that suffer from hypothyroidism. Age, excessive body weight, increasing of arterial blood pressure, and hypoadiponectinemia play a significant role in the left ventricle myocardial remodeling.</p></abstract><trans-abstract xml:lang="ru"><p/></trans-abstract><kwd-group xml:lang="en"><kwd>adiponectin</kwd><kwd>resistin</kwd><kwd>leptin</kwd><kwd>hypothyroidism</kwd><kwd>fat metabolism</kwd><kwd>echocardiography</kwd><kwd>diastolic dysfunction</kwd><kwd>left ventricular hypertrophy</kwd><kwd>myocardial remodeling</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>адипонектин</kwd><kwd>резистин</kwd><kwd>лептин</kwd><kwd>гипотиреоз</kwd><kwd>жировой обмен</kwd><kwd>эхокардиография</kwd><kwd>диастолическая дисфункция</kwd><kwd>гипертрофия левого желудочка</kwd><kwd>ремоделирование миокарда</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><citation-alternatives><mixed-citation xml:lang="en">1. Петунина Н.А., Трухина Л.В. Гипотиреоз. Русский медицинский журнал 2013;(5):1–3. [Petunina N.A., Trukhina L.V. Hypothyroidism. Rysskiy meditsinskiy zhyrnal = Russian Medical Journal 2013;(5):1–3. (In Russ.)].</mixed-citation><mixed-citation xml:lang="ru">Петунина Н.А., Трухина Л.В. Гипотиреоз. Русский медицинский журнал 2013;(5):1–3. [Petunina N.A., Trukhina L.V. Hypothyroidism. Rysskiy meditsinskiy zhyrnal = Russian Medical Journal 2013;(5):1–3. (In Russ.)].</mixed-citation></citation-alternatives></ref><ref id="B2"><label>2.</label><citation-alternatives><mixed-citation xml:lang="en">2. Петунина Н.А. К вопросу о состоянии сердечно-сосудистой системы при нарушении функции щитовидной железы. Фарматека 2007;(3):51–6. [Petunina N.A. Regarding the issues of the status of the cardiovascular system with violations of the thyroid gland functioning. Farmateka 2007;(3):51–6. (In Russ.)].</mixed-citation><mixed-citation xml:lang="ru">Петунина Н.А. К вопросу о состоянии сердечно-сосудистой системы при нарушении функции щитовидной железы. Фарматека 2007;(3):51–6. [Petunina N.A. Regarding the issues of the status of the cardiovascular system with violations of the thyroid gland functioning. Farmateka 2007;(3):51–6. (In Russ.)].</mixed-citation></citation-alternatives></ref><ref id="B3"><label>3.</label><citation-alternatives><mixed-citation xml:lang="en">3. Килейников Д.В., Орлов Ю.А., Горбачева С.А. и др. Особенности центральной и периферической гемодинамики у больных артериальной гипертензией при первичном гипотиреозе и сахарном диабете 2 типа. Терапевт 2012;(5):15–7. [Kileynikov D.V., Orlov Yu.A., Gorbachyova S.A. et al. Peculiarities of the central and peripheral hemodynamics of patients with arterial hypertension with primary hypothyroidism and type 2 diabetes mellitus. Terapevt = Therapeutist 2012;(5): 15–7. (In Russ.)].</mixed-citation><mixed-citation xml:lang="ru">Килейников Д.В., Орлов Ю.А., Горбачева С.А. и др. Особенности центральной и периферической гемодинамики у больных артериальной гипертензией при первичном гипотиреозе и сахарном диабете 2 типа. Терапевт 2012;(5):15–7. [Kileynikov D.V., Orlov Yu.A., Gorbachyova S.A. et al. Peculiarities of the central and peripheral hemodynamics of patients with arterial hypertension with primary hypothyroidism and type 2 diabetes mellitus. Terapevt = Therapeutist 2012;(5): 15–7. (In Russ.)].</mixed-citation></citation-alternatives></ref><ref id="B4"><label>4.</label><citation-alternatives><mixed-citation xml:lang="en">4. Hueston W.J. Pearson W.S. Subclinical hypothyroidism and the risk of hypercholesterolemia. Ann Fam Med 2004;2(4):351–5.</mixed-citation><mixed-citation xml:lang="ru">Hueston W.J. Pearson W.S. Subclinical hypothyroidism and the risk of hypercholesterolemia. Ann Fam Med 2004;2(4):351–5.</mixed-citation></citation-alternatives></ref><ref id="B5"><label>5.</label><citation-alternatives><mixed-citation xml:lang="en">5. Петунина Н.А., Альтшулер Н.Э. Сравнительный анализ уровней адипонектина, лептина, резистина, показателей липидного обмена и инсулинорезистентности при субклиническом гипотиреозе в зависимости от наличия/отсутствия заместительной терапии левотироксином. Эндокринология: новости, мнения, обучение 2013;(2):27–31. [Petunina N.A., Altschuler N.E. Comparative analysis of the levels of adiponectin, leptin, resistin, lipid metabolism and insulin resistance indicators with subclinical hypothyroidism depending on the availability/absence of replacement therapy with levothyroxine. Endocrinology: news, opinion, training 2013;(2):27–31. (In Russ.)].</mixed-citation><mixed-citation xml:lang="ru">Петунина Н.А., Альтшулер Н.Э. Сравнительный анализ уровней адипонектина, лептина, резистина, показателей липидного обмена и инсулинорезистентности при субклиническом гипотиреозе в зависимости от наличия/отсутствия заместительной терапии левотироксином. Эндокринология: новости, мнения, обучение 2013;(2):27–31. [Petunina N.A., Altschuler N.E. Comparative analysis of the levels of adiponectin, leptin, resistin, lipid metabolism and insulin resistance indicators with subclinical hypothyroidism depending on the availability/absence of replacement therapy with levothyroxine. Endocrinology: news, opinion, training 2013;(2):27–31. (In Russ.)].</mixed-citation></citation-alternatives></ref><ref id="B6"><label>6.</label><citation-alternatives><mixed-citation xml:lang="en">6. Dekker J.M., Funahashi T., Nijpels. G. et al. Prognostic value of adiponectin of cardiovascular disease and mortality. J Clin Endocrinol Metab 2008;93(4):1489–96.</mixed-citation><mixed-citation xml:lang="ru">Dekker J.M., Funahashi T., Nijpels. G. et al. Prognostic value of adiponectin of cardiovascular disease and mortality. J Clin Endocrinol Metab 2008;93(4):1489–96.</mixed-citation></citation-alternatives></ref><ref id="B7"><label>7.</label><citation-alternatives><mixed-citation xml:lang="en">7. Farvid M.S., Ng T.W., Chan D.C. et al. Association of adiponectin and resistin with adipose tissue compartments, insulin resistance and dyslipidaemia. Diabetes Obes Metab 2005;7(4):406–13.</mixed-citation><mixed-citation xml:lang="ru">Farvid M.S., Ng T.W., Chan D.C. et al. Association of adiponectin and resistin with adipose tissue compartments, insulin resistance and dyslipidaemia. Diabetes Obes Metab 2005;7(4):406–13.</mixed-citation></citation-alternatives></ref><ref id="B8"><label>8.</label><citation-alternatives><mixed-citation xml:lang="en">8. Волов Н.А., Адамов П.Б., Лебедева А.Ю. и др. Лептин – новый фактор риска сердечно-сосудистых заболеваний. Терапевт 2011;(8):50–4. [Volov N.A., Adamov P.B., Lebedeva A.Yu. et al. Leptin as a new risk factor of cardiovascular diseases. Terapevt = Therapeutist 2011;(8):50–4. (In Russ.)].</mixed-citation><mixed-citation xml:lang="ru">Волов Н.А., Адамов П.Б., Лебедева А.Ю. и др. Лептин – новый фактор риска сердечно-сосудистых заболеваний. Терапевт 2011;(8):50–4. [Volov N.A., Adamov P.B., Lebedeva A.Yu. et al. Leptin as a new risk factor of cardiovascular diseases. Terapevt = Therapeutist 2011;(8):50–4. (In Russ.)].</mixed-citation></citation-alternatives></ref><ref id="B9"><label>9.</label><citation-alternatives><mixed-citation xml:lang="en">9. Lang R.M., Bierig M., Devereux R.B. et al. Recommendations for chamber quantification. Eur J Echocardiogr 2006;7(2):79–108.</mixed-citation><mixed-citation xml:lang="ru">Lang R.M., Bierig M., Devereux R.B. et al. Recommendations for chamber quantification. Eur J Echocardiogr 2006;7(2):79–108.</mixed-citation></citation-alternatives></ref><ref id="B10"><label>10.</label><citation-alternatives><mixed-citation xml:lang="en">10. Васюк Ю.А. Возможности и ограничения эхокардиографического исследования в оценке ремоделирования левого желудочка при ХСН. Сердечная недостаточность 2003;4(2):107–10. [Vasyuk Yu.A. Possibilities and limitation f echocardiography examination in the evaluation of left ventricular remodeling with CHF. Serdechnaya nedostatochnost = Heart Failure 2003;4(2):107–10. (In Russ.)].</mixed-citation><mixed-citation xml:lang="ru">Васюк Ю.А. Возможности и ограничения эхокардиографического исследования в оценке ремоделирования левого желудочка при ХСН. Сердечная недостаточность 2003;4(2):107–10. [Vasyuk Yu.A. Possibilities and limitation f echocardiography examination in the evaluation of left ventricular remodeling with CHF. Serdechnaya nedostatochnost = Heart Failure 2003;4(2):107–10. (In Russ.)].</mixed-citation></citation-alternatives></ref><ref id="B11"><label>11.</label><citation-alternatives><mixed-citation xml:lang="en">11. Шишкин А.Н., Худяков Н.В., Темная Н.В., Смирнов В.В. Влияние ожирения на ремоделирование миокарда у женщин в перименопаузу. Вестник Санкт-Петербургского университета 2013;11(4):13–22. [Shishkin A.N., Khudyakov N.V., Tyomnaya N.V., Smirnov V.V. Effect of obesity on myocardial remodeling of perimenopausal women. Vestnik Sankt- Peterburgskogo universiteta = St. Petersburg University Herald 2013;11(4):13–22. (In Russ.)].</mixed-citation><mixed-citation xml:lang="ru">Шишкин А.Н., Худяков Н.В., Темная Н.В., Смирнов В.В. Влияние ожирения на ремоделирование миокарда у женщин в перименопаузу. Вестник Санкт-Петербургского университета 2013;11(4):13–22. [Shishkin A.N., Khudyakov N.V., Tyomnaya N.V., Smirnov V.V. Effect of obesity on myocardial remodeling of perimenopausal women. Vestnik Sankt- Peterburgskogo universiteta = St. Petersburg University Herald 2013;11(4):13–22. (In Russ.)].</mixed-citation></citation-alternatives></ref><ref id="B12"><label>12.</label><citation-alternatives><mixed-citation xml:lang="en">12. Преображенский Д.В., Сидоренко Б.А., Маренич А.В. и др. Современная терапия артериальной гипертензии (Рекомендации Европейского общества по гипертензии и Европейского общества кардиологов, 2003 г.). Кардиология 2003;43(12):91–103. [Preobrazhenskiy D.V., Sidorenko B.A., Marenich A.V. et al. Modern therapy of arterial hypertension (Recommendations of the European Society of hypertension and the European Society of cardiology, 2003). Kardiologiya = Cardiology 2003;43(12):91–103. (In Russ.)].</mixed-citation><mixed-citation xml:lang="ru">Преображенский Д.В., Сидоренко Б.А., Маренич А.В. и др. Современная терапия артериальной гипертензии (Рекомендации Европейского общества по гипертензии и Европейского общества кардиологов, 2003 г.). Кардиология 2003;43(12):91–103. [Preobrazhenskiy D.V., Sidorenko B.A., Marenich A.V. et al. Modern therapy of arterial hypertension (Recommendations of the European Society of hypertension and the European Society of cardiology, 2003). Kardiologiya = Cardiology 2003;43(12):91–103. (In Russ.)].</mixed-citation></citation-alternatives></ref><ref id="B13"><label>13.</label><citation-alternatives><mixed-citation xml:lang="en">13. Biondi B. Mechanisms in endocrinology: Heart failure and thyroid dysfunction. Eur J Endocrinol 2012;167(5):609–18.</mixed-citation><mixed-citation xml:lang="ru">Biondi B. Mechanisms in endocrinology: Heart failure and thyroid dysfunction. Eur J Endocrinol 2012;167(5):609–18.</mixed-citation></citation-alternatives></ref><ref id="B14"><label>14.</label><citation-alternatives><mixed-citation xml:lang="en">14. Килейников Д.В., Семенычев Д.Г., Мазур В.В., Мазур Е.С. Влияние компенсации тиреоидного статуса на функциональное состояние сердечно-сосудистой системы у больных первичным гипотиреозом. Терапевт 2014;(1):25–30. [Kileynikov D.V., Semenychev D.G., Mazur V.V., Mazur E.S. Effect of compensation of thyroid status on the functional state of the cardiovascular system of patients with primary hypothyroidism. Terapevt = Therapeutist 2014;(1):25–30. (In Russ.)].</mixed-citation><mixed-citation xml:lang="ru">Килейников Д.В., Семенычев Д.Г., Мазур В.В., Мазур Е.С. Влияние компенсации тиреоидного статуса на функциональное состояние сердечно-сосудистой системы у больных первичным гипотиреозом. Терапевт 2014;(1):25–30. [Kileynikov D.V., Semenychev D.G., Mazur V.V., Mazur E.S. Effect of compensation of thyroid status on the functional state of the cardiovascular system of patients with primary hypothyroidism. Terapevt = Therapeutist 2014;(1):25–30. (In Russ.)].</mixed-citation></citation-alternatives></ref></ref-list></back></article>
